Literature DB >> 22529490

Metoclopramide-induced oculogyric crisis presenting as encephalitis in a young girl.

Jayavardhana Arumugam1, A M Vijayalakshmi.   

Abstract

Drug-related dystonic reactions are not uncommon and often misdiagnosed as encephalitis, seizures, tetanus, tetany, etc. Eliciting thorough history is important to avoid unnecessary investigations and treatments as these are potentially reversible reactions. Metoclopramide-induced oculogyric crisis is described in this case report.

Entities:  

Keywords:  Diphenhydramine; metoclopramide; oculogyric crisis

Year:  2012        PMID: 22529490      PMCID: PMC3326927          DOI: 10.4103/0253-7613.93867

Source DB:  PubMed          Journal:  Indian J Pharmacol        ISSN: 0253-7613            Impact factor:   1.200


Introduction

Adverse effects of commonly used drugs are often overlooked. Oculogyric crisis is a type of acute dystonia which occurs with many drugs. A widely used antiemetic metoclopramide can produce oculogyric crisis in children.[12] We report a case of 14-year–old girl with the referral diagnosis of acute encephalitis who actually had metoclopramide-induced oculogyric dystonic reaction.

Case Report

A 14-year-old girl was prescribed metronidazole (400 mg tid), metoclopramide (10 mg tid), paracetamol (500 mg tid) and ORS (200 ml pack) at an outpatient clinic on 30/08/2010 for fever, loose stools and vomiting of 2-day duration. She had taken the above drugs in the morning and in the afternoon. Around 6 pm in the evening, she developed agitation, head ache, difficulty in swallowing and deviation of eyes. She was suspected to have acute encephalitis and computerized tomography (CT) scan of the brain was done. As CT brain was normal she was referred to us for further management. On admission in emergency department at PSG hospitals (Coimbatore) she was conscious, unable to speak and eyes were deviated upwards with hyperextension of neck [Figure 1]. She had rigidity in neck and upper trunk muscles which mimicked meningeal signs. Her motor and sensory systems were normal. She had no involuntary movements and her pupils were normal in size and reacting. Other systemic examination and vitals were normal. Investigations including serum electrolytes and sepsis workup were normal. We temporally correlated this to metoclopramide-induced dystonic reaction and she was given oral diphenhydramine 50 mg two doses as therapeutic and diagnostic. She recovered completely over 12 hours. The Naranjo algorithm classifies this reaction as a “possible” adverse drug reaction.[3]
Figure 1

Oculogyric crisis in a patient receiving metoclopramide

Oculogyric crisis in a patient receiving metoclopramide

Discussion

Acute dystonias are extrapyrmidal side effects due to blockade of postsynaptic dopamine receptors in corpus striatum.[4] These reactions are known to be produced by drugs like phenothiazines, butyrophenons, metoclopramide, tricyclic antidepressants, lithium, α-methyldopa, reserpine, trimethobenzamide, diazoxide, organophosphates, phencyclidine, ketamine, phenytoin, carbamazepine, chloroquine and antihistamines.[56] These dystonic reactions are due to sustained muscle contractions and usually present as buccolingual, torticollic, oculogyric and opisthotonic forms. Oculogyric crisis is characterized by bilateral sustained upward elevation of visual gaze with hyperextension of the neck.[7] Acute dystonias may be confused with encephalitis, complex partial seizures, tetanus, strychnine poisoning and hypocalcemic tetany.[8] Metoclopramide hydrochloride is an antiemetic, prokinetic agent and potent dopamine-receptor antagonist. The incidence of the acute dystonias following metoclopramide use is 0.2% with female preponderance up to 70%.[9] The ‘dystonic’ dose of metoclopramide and risk factors for this reaction remain unclear as there are case reports of oculogyric crisis even in recommended doses including this case.[10-13] It is believed that duration of the symptoms corresponds to half life of the drug and intravenous diphenhydramine, 1–2 mg/kg/dose, may rapidly reverse the drug-related dystonia.[13]
  12 in total

1.  Prescription-event monitoring and reporting of adverse drug reactions.

Authors:  E Heeley; J Riley; D Layton; L V Wilton; S A Shakir
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

2.  A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis.

Authors:  Emil Lou; Nuhad Abou-Zeid
Journal:  South Med J       Date:  2006-11       Impact factor: 0.954

3.  Oculogyric crisis after metoclopramide therapy.

Authors:  M Edwards; M W Koo; R K Tse
Journal:  Optom Vis Sci       Date:  1989-03       Impact factor: 1.973

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  [Acute dystonia caused by metoclopramide (Afipran) therapy].

Authors:  E M Hagen; E Farbu; L Bindoff
Journal:  Tidsskr Nor Laegeforen       Date:  2001-08-10

6.  [Clinical and therapeutical features in 135 patients with dystonia: experience of movement disorders unity of the Hospital de Clínicas of the Universidade Federal do Paraná].

Authors:  G Fabiani; H A Teive; F Germiniani; D Sá; L C Werneck
Journal:  Arq Neuropsiquiatr       Date:  1999-09       Impact factor: 1.420

7.  Metoclopramide induced dystonia in children: two case reports.

Authors:  Uluc Yis; Durgul Ozdemir; Murat Duman; Nurettin Unal
Journal:  Eur J Emerg Med       Date:  2005-06       Impact factor: 2.799

8.  Extrapyramidal reactions with metoclopramide.

Authors:  D N Bateman; M D Rawlins; J M Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

9.  Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.

Authors:  J C Allen; R Gralla; L Reilly; M Kellick; C Young
Journal:  J Clin Oncol       Date:  1985-08       Impact factor: 44.544

Review 10.  Metoclopramide-induced movement disorders. Clinical findings with a review of the literature.

Authors:  L G Miller; J Jankovic
Journal:  Arch Intern Med       Date:  1989-11
View more
  2 in total

Review 1.  The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis.

Authors:  Melissa Lau Moon Lin; Paula D Robinson; Jacqueline Flank; Lillian Sung; L Lee Dupuis
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

2.  Metoclopramide-induced Acute Dystonia Misdiagnosed as an Epileptic Seizure in a Lupus Patient.

Authors:  Airenakho Emorinken; Oluwaseun Remi Agbadaola
Journal:  J Epilepsy Res       Date:  2021-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.